Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Edwards Lifesciences Corp reaffirms FY 2013 guidance-Conference Call

Monday, 9 Dec 2013 08:00am EST 

Edwards Lifesciences Corp:Reaffirms FY 2013 total sales and earnings guidance, which includes diluted earnings per share of $3.00 to $3.10, excluding special items.FY 2013 revenue of $2.04 bln, EPS of $3.05 - Thomson Reuters I/B/E/S Estimates. 

Company Quote

1.59 +1.25%
26 Nov 2014